FREMONT, Calif., Oct. 20, 2014 /PRNewswire/ -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS) announced the launch of an automated solution for Agilent’s SureSelectXT Target Enrichment workflow on the Apollo 324TM Next Generation Sequencing (NGS) sample preparation system. WaferGen responded to customers’ unmet needs for a cost effective and flexible automated target capture solution. The Apollo 324TM protocols were designed to enable researchers to utilize Agilent’s SureSelectXT Reagent Kits with a decreased turnaround time, thereby improving throughput with the expanded flexibility to prepare a wide range of samples per run. This solution will be of great use to clinical CLIA labs, as well as clinical research institutions.
“The bottleneck of implementing exome capture on a routine basis is that existing workflows are long and tedious and it can be challenging to get reproducible results. We participated in WaferGen’s Apollo 324 Early Access Program for automating SureSelect exome capture and showed that WaferGen’s platform massively reduced our hands-on time and gave us the flexibility to prepare any number of samples per run with consistent results. With the Apollo 324, we can now offer a full scale exome service to our customers,” stated Dr. Jason Steel from The Center for Personalized Diagnostics at Arizona State University.
As previously announced, technical data will be presented at the American Society for Human Genetics 2014 Annual Meeting in San Diego in a paper titled “Automation of hybridization based capture technologies on the Apollo 324 NGS Library Prep System” on Tuesday, October 21, 2:00 3:00 pm.
The Apollo 324TM NGS Library Prep System is a compact and flexible system that enables rapid and full walk-away automation of a wide variety of Next Generation Sequencing applications. WaferGen also offers complete solutions with PrepXTM reagent kits that are designed specifically for ease-of-use with Apollo 324TM automated protocols. PrepXTM reagents are color-coded and prealiquotted with the necessary volume per reaction, significantly reducing hands-on time and operator error. WaferGen continues to develop new applications for Apollo 324TM, including second generation whole exome solutions and plans to launch additional solutions in the first quarter of 2015.
About WaferGen
WaferGen Bio-systems, Inc. is a life science company that offers innovative genomic solutions for clinical testing and research. The SmartChip MyDesignTM Real-Time PCR System is a high-throughput genetic analysis platform for profiling and validating molecular biomarkers via microRNA and mRNA gene expression profiling, as well as single nucleotide polymorphism (SNP) genotyping. The SmartChip TETM System is a novel product offering for target enrichment geared towards clinical Next-Gen sequencing (NGS). The Seq-ReadyTM TE System, powered by SmartChipTM massively-parallel single-plex PCR technology, is an innovative one-step target enrichment and library preparation solution. The Company now also offers the Apollo 324TM product line used in library preparation for NGS. These three complementary technologies offer a powerful set of tools enabling more accurate, faster and cheaper genetic analysis based on Next-Gen Sequencing and Real-Time PCR.
For additional information, please see http://www.wafergen.com.
Investor Contacts:
ICR, Inc.
Bob Yedid
bob.yedid@icrinc.com
646-277-1250
WaferGen Bio-systems, Inc.
Ivan Trifunovich
ivan.trifunovich@wafergen.com
(510) 651-4450
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/wafergen-bio-systems-announces-the-launch-of-exome-capture-solutions-on-its-next-generation-sequencing-ngs-sample-preparation-platform-apollo-324-181173327.html
SOURCE WaferGen Bio-systems, Inc.
Help employers find you! Check out all the jobs and post your resume.
